Related Experiment Videos
Autoimmune liver disease in children
1Institute of Liver Studies, King's College Hospital, Denmark Hill, London SE5 9RS, United Kingdom. giorgina.vergani@kcl.ac.uk
Annals of the Academy of Medicine, Singapore
|May 30, 2003
Summary
Autoimmune liver diseases like autoimmune hepatitis (AIH) and autoimmune sclerosing cholangitis (ASC) share inflammatory features and autoantibodies. Both pediatric and adult forms respond to immunosuppression, though ASC can progress.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Autoimmune liver disorders present with inflammation, autoantibodies, and elevated IgG, lacking other identifiable causes.
- Autoimmune hepatitis (AIH) and autoimmune sclerosing cholangitis (ASC) are key examples, with AIH classified into two types based on autoantibody profiles (SMA/ANA or LKM1).
Discussion:
- ASC is the predominant pediatric sclerosing cholangitis, often clinically and histologically mirroring AIH.
- Both conditions exhibit high IgG, non-organ specific autoantibodies, and interface hepatitis, with diagnosis of ASC confirmed by cholangiography.
Key Insights:
- Children with ASC demonstrate satisfactory response to immunosuppression, comparable to AIH in remission rates, relapse, and biochemical normalization.
- Despite treatment, cholangiopathy progression and potential evolution from AIH to ASC over time are observed.
Outlook:
- The precise relationship between juvenile autoimmune sclerosing cholangitis and AIH requires further investigation to determine if they are distinct entities or facets of the same condition.
- Continued research is needed to understand the long-term implications and potential distinct pathways of these autoimmune liver diseases.